Join
Live feed
·
PRReleasevia Quantisnow
Viridian Therapeutics Inc. logo

Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease

ByQuantisnow·Wall Street's wire, on your screen.
VRDN· Viridian Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRDN (Viridian Therapeutics Inc.) and more on Quantisnow.